Eggenhuizen, Peter J. http://orcid.org/0000-0002-7102-3547
Cheong, Rachel M. Y. http://orcid.org/0009-0009-6977-1333
Lo, Cecilia
Chang, Janet
Ng, Boaz H.
Ting, Yi Tian
Monk, Julie A.
Loh, Khai L. http://orcid.org/0000-0002-2211-2404
Broury, Ashraf http://orcid.org/0009-0008-0729-5223
Tay, Elean S. V.
Shen, Chanjuan
Zhong, Yong
Lim, Steven http://orcid.org/0000-0003-3663-0736
Chung, Jia Xi
Kandane-Rathnayake, Rangi
Koelmeyer, Rachel
Hoi, Alberta
Chaudhry, Ashutosh
Manzanillo, Paolo
Snelgrove, Sarah L. http://orcid.org/0009-0001-0031-6414
Morand, Eric F. http://orcid.org/0000-0002-9507-3338
Ooi, Joshua D. http://orcid.org/0000-0003-3328-2561
Funding for this research was provided by:
Lupus Research Alliance (100012051, 588087 and 850279)
Department of Health | National Health and Medical Research Council (501100000925, 2017877)
Amgen (100002429, 2021026213-001)
U.S. Department of Defense (100000005, LR210065)
Article History
Received: 12 March 2023
Accepted: 12 January 2024
First Online: 6 February 2024
Competing interests
: The authors declare the following competing interests: Relevant funding was awarded by Lupus Research Alliance Inc., Funder ID 100012051, 588087, and 850279 (J.D.O.), National Health and Medical Research Council (NHMRC), Funder ID 501100000925, 2017877 (J.D.O.), Amgen Inc., Funder ID 100002429, 2021026213-001 (J.D.O.), United States Department of Defense, Funder id 100000005, LR210065 (J.D.O.). The research has been partially supported by Amgen. PCT patent application (PCT/AU2021/050254) has been filed by Monash University as the sole applicant. Inventors: J.D.O., P.J.E., and E.F.M. The remaining authors declare no competing interests.